000 | 010130000a22003010004500 | ||
---|---|---|---|
008 | 110526t xxu||||| |||| 00| 0 eng d | ||
020 | _a9781841844008 | ||
040 | _cVAD | ||
041 | _aEngels | ||
100 |
_aMattick, Richard P. _eed. _961423 |
||
245 | _aPharmacotherapies for the treatment of opioid dependence : efficacy, cost-effectiveness, and implementation guidelines | ||
260 |
_aNew York _bInforma Healthcare _c2009 |
||
300 | _aXIII, 503 p. | ||
650 |
_abuprenorfine _961424 |
||
650 |
_adrugs _961425 |
||
650 |
_afarmacotherapie _961426 |
||
650 |
_aheroïne _961427 |
||
650 |
_aheroïneverstrekking _961428 |
||
650 |
_ahulpverlening _961429 |
||
650 |
_aLAAM _961430 |
||
650 |
_amethadon _961431 |
||
650 |
_analtrexon _961432 |
||
650 |
_abehandelrichtlijnen _961433 |
||
700 |
_aAli, Robert _eed. _961434 |
||
700 |
_aLintzeris, Nicholas _eed. _961435 |
||
942 |
_2ddc _cARTIKEL |
||
952 |
_70 _p119980 _cOPENKAST _40 _00 _bVAD _yboek _10 _o440 MATT _d20091119 _aVAD |
||
999 |
_c14387 _d14387 |